61 related articles for article (PubMed ID: 20081768)
1. Are bio-absorbable stents the future of SFA treatment?
Peeters P; Keirse K; Verbist J; Deloose K; Bosiers M
J Cardiovasc Surg (Torino); 2010 Feb; 51(1):121-4. PubMed ID: 20081768
[TBL] [Abstract][Full Text] [Related]
2. Are drug-eluting stents the future of SFA treatment?
Bosiers M; Deloose K; Keirse K; Verbist J; Peeters P
J Cardiovasc Surg (Torino); 2010 Feb; 51(1):115-9. PubMed ID: 20081767
[TBL] [Abstract][Full Text] [Related]
3. Stent puncture for recanalization of occluded superficial femoral artery stents.
Gandini R; Del Giudice C; Assako Ondo EP; Spano S; Stefanini M; Simonetti G
J Endovasc Ther; 2012 Feb; 19(1):30-3. PubMed ID: 22313198
[TBL] [Abstract][Full Text] [Related]
4. What is lining your full metal jacket?
Gray BH
Catheter Cardiovasc Interv; 2011 Jun; 77(7):1063-4. PubMed ID: 21598359
[No Abstract] [Full Text] [Related]
5. Mid-term outcome after endovascular therapy in the superficial femoral and popliteal artery using long stents.
Schoenefeld E; Donas KP; Schönefeld T; Osada N; Austermann M; Torsello G
Vasa; 2012 Jan; 41(1):49-56. PubMed ID: 22247060
[TBL] [Abstract][Full Text] [Related]
6. The potential role of DES in peripheral in-stent restenosis.
Zeller T; Macharzina R; Tepe G
J Cardiovasc Surg (Torino); 2010 Aug; 51(4):561-5. PubMed ID: 20671640
[TBL] [Abstract][Full Text] [Related]
7. Role of total endoluminal superficial femoral artery bypass.
Gable D
J Cardiovasc Surg (Torino); 2011 Oct; 52(5):683-700. PubMed ID: 21799474
[TBL] [Abstract][Full Text] [Related]
8. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
9. First clinical experience with the Innova versus the Protege EverFlex self-expanding bare metal stents in superficial femoral artery occlusions.
Gabrielli R; Rosati MS; Chiappa R; Millarelli M; Marcuccio L; Siani A; Caselli G
Thorac Cardiovasc Surg; 2015 Mar; 63(2):158-63. PubMed ID: 25602844
[TBL] [Abstract][Full Text] [Related]
10. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
11. Refining stent technologies for femoral interventions.
Bosiers M; Deloose K; Callaert J; Maene L; Keirse K; Verbist J; Peeters P
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):465-73. PubMed ID: 22854526
[TBL] [Abstract][Full Text] [Related]
12. Regarding: Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?
Teebken OE; Bauermeister G; Pichlmaier AM
Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):118. PubMed ID: 18440251
[No Abstract] [Full Text] [Related]
13. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study.
Werner M; Micari A; Cioppa A; Vadalà G; Schmidt A; Sievert H; Rubino P; Angelini A; Scheinert D; Biamino G
JACC Cardiovasc Interv; 2014 Mar; 7(3):305-12. PubMed ID: 24529932
[TBL] [Abstract][Full Text] [Related]
14. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
15. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
Waksman R; Pakala R
EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Nitinol Stents Using a 3-Dimensional Printed Superficial Femoral Artery Model: A Preliminary Study.
Girsowicz E; Georg Y; Seiller H; Lejay A; Thaveau F; Heim F; Chakfe N
Ann Vasc Surg; 2016 May; 33():1-10. PubMed ID: 26597246
[TBL] [Abstract][Full Text] [Related]
17. Long-term results with the Palmaz stent in the superficial femoral artery.
Bergeron P; Pinot JJ; Poyen V; Benichou H; Khanoyan P; Rudondy P; Wang Y; Chiarandini S; el Hussein R; Rieu R
J Endovasc Surg; 1995 May; 2(2):161-7. PubMed ID: 9234129
[TBL] [Abstract][Full Text] [Related]
18. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM
J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents for treatment of focal infrapopliteal lesions.
Rastan A; Noory E; Zeller T
Vasa; 2012 Mar; 41(2):90-5. PubMed ID: 22403126
[TBL] [Abstract][Full Text] [Related]
20. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
